Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Oktober 2025 08:23 ET | Quelle: The Ritedose Corporation

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

With the addition of Tobramycin Inhalation Solution, Ritedose now provides the largest nebulized drug portfolio in the country.
29. April 2019 12:13 ET | Quelle: Reports And Data

Aminoglycosides Market To Reach USD 2.01 Billion By 2026 | Reports And Data

Growing application of digital health agenda by ERS and WHO for tuberculosis eradication is fueling the market growth. Market Size – USD 1.50 Billion in 2018, Market Growth - CAGR of 3.7%, Market...
13. Juli 2015 03:53 ET | Quelle: Persistence Market Research

U.S Bacterial Conjunctivitis Drugs Market Will Reach US& 439.8 Million in 2024 by Persistence Market Research

New York, July 13, 2015 (GLOBE NEWSWIRE) -- According to a new market report published by Persistence Market Research "The U.S Market Study on Bacterial Conjunctivitis Drugs: fluoroquinolones to be...